The effects of the novel HSP-coinducer bimoclomol was studied on action pot
entials, ionic currents and [Ca2+](i) transients in isolated canine ventric
ular myocytes using conventional microelectrode techniques and whole cell v
oltage clamp combined with fluorescent [Ca2+](i) measurements. Contractilit
y was studied in right ventricular trabeculae, All preparations were paced
with a frequency of 0.2 Hz. Bimoclomol (100 mu M) shortened action potentia
l duration measured at 50% repolarization, but lengthened action potentials
at the 90% repolarization level, decreased action potential amplitude and
maximum depolarization velocity in a reversible manner. In voltage clamped
myocytes, the drug activated a steady-state outward current at positive mem
brane potentials leaving the peak inward current unaffected, [Ca2+](i) tran
sients, measured under voltage clamp control, were increased in amplitude a
nd had accelerated decay kinetics in the presence of the compound, in addit
ion to reduction of diastolic [Ca2+](i). Bimoclomol significantly decreased
the force of contraction in right ventricular trabeculae. Comparison of pr
esent data to previous results indicate that the cardiac effects of bimoclo
mol strongly depend on actual experimental conditions. The reduced contract
ility in spite of the increased amplitude of [Ca2+](i) transients suggests
that 100 mu M bimoclomol may decrease calcium sensitivity of the contractil
e apparatus. (C) 2000 Elsevier Science Inc. All rights reserved.